Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colvin

Showing results (341-350 of 352) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant gliomaH S Friedman, R E McLendon, T Kerby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Irinotecan therapy in adults with recurrent or progressive malignant gliomaH S Friedman, W P Petros, A H Friedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaH S Friedman, J Pluda, J A Quinn, et al.
JACC. Heart Failure|June 5, 2026
Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT StudyPalak Shah, Paul J Kim, Kelly H Schlendorf, et al.
Journal of the American College of Cardiology|April 5, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of the American College of Cardiology|April 5, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Circulation|April 1, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Circulation|April 1, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of Cardiac Failure|April 4, 2022
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive SummaryPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Plos One|February 6, 2023
Profiles of COVID-19 vaccine hesitancy by race and ethnicity in eastern PennsylvaniaKenya M Colvin, Kennedy S Camara, Latasha S Adams, et al.
Pageof 36

Showing results (341-350 of 352) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant gliomaH S Friedman, R E McLendon, T Kerby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Irinotecan therapy in adults with recurrent or progressive malignant gliomaH S Friedman, W P Petros, A H Friedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaH S Friedman, J Pluda, J A Quinn, et al.
JACC. Heart Failure|June 5, 2026
Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT StudyPalak Shah, Paul J Kim, Kelly H Schlendorf, et al.
Journal of the American College of Cardiology|April 5, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of the American College of Cardiology|April 5, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Circulation|April 1, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Circulation|April 1, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of Cardiac Failure|April 4, 2022
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive SummaryPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Plos One|February 6, 2023
Profiles of COVID-19 vaccine hesitancy by race and ethnicity in eastern PennsylvaniaKenya M Colvin, Kennedy S Camara, Latasha S Adams, et al.
Pageof 36